- Home
- SURG vs NTRB Comparison
SURG vs NTRB Comparison
Compare SURG & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- NTRB
- Stock Information
- Founded
- SURG 2006
- NTRB 2016
- Country
- SURG United States
- NTRB United States
- Employees
- SURG N/A
- NTRB N/A
- Industry
- SURG Advertising
- NTRB Industrial Specialties
- Sector
- SURG Consumer Discretionary
- NTRB Health Care
- Exchange
- SURG Nasdaq
- NTRB Nasdaq
- Market Cap
- SURG 59.4M
- NTRB 59.1M
- IPO Year
- SURG N/A
- NTRB N/A
- Fundamental
- Price
- SURG $2.75
- NTRB $6.50
- Analyst Decision
- SURG Strong Buy
- NTRB Buy
- Analyst Count
- SURG 1
- NTRB 1
- Target Price
- SURG $8.75
- NTRB $13.00
- AVG Volume (30 Days)
- SURG 226.8K
- NTRB 28.3K
- Earning Date
- SURG 05-13-2025
- NTRB 05-30-2025
- Dividend Yield
- SURG N/A
- NTRB N/A
- EPS Growth
- SURG N/A
- NTRB N/A
- EPS
- SURG N/A
- NTRB N/A
- Revenue
- SURG $40,029,467.00
- NTRB $2,139,537.00
- Revenue This Year
- SURG $103.68
- NTRB $571.50
- Revenue Next Year
- SURG $51.08
- NTRB $577.37
- P/E Ratio
- SURG N/A
- NTRB N/A
- Revenue Growth
- SURG N/A
- NTRB 2.60
- 52 Week Low
- SURG $1.05
- NTRB $3.72
- 52 Week High
- SURG $4.38
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- SURG 48.39
- NTRB 62.26
- Support Level
- SURG $3.01
- NTRB $5.24
- Resistance Level
- SURG $3.17
- NTRB $5.84
- Average True Range (ATR)
- SURG 0.27
- NTRB 0.39
- MACD
- SURG -0.04
- NTRB 0.09
- Stochastic Oscillator
- SURG 27.17
- NTRB 96.93
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.